Berkenboom Guy, Preumont Nicolas, Pradier Olivier, Goldman Michel, Carpentier Yvon, Vachiery Jean-Luc, Antoine Martine
Department of Cardiology, Erasme Hospital, Free University of Brussels, Brussels, Belgium.
Am J Cardiol. 2006 Feb 15;97(4):561-6. doi: 10.1016/j.amjcard.2005.09.088. Epub 2006 Jan 4.
Coronary hypersensitivity to serotonin promotes platelet aggregation, entailing the progression of the atherosclerotic process. This abnormality is a common finding in cardiac transplant recipients and may be triggered by reactive oxygen species, which plays a main role in the inflammatory process. Hence, this study aimed to determine the influence of intimal hyperplasia on this abnormality and its reversibility after acute supplementation with the superoxide anion scavenger vitamin C. Therefore, intracoronary injections of serotonin (3 microg), bradykinin (600 ng), and nitroglycerin (isosorbide dinitrate 200 microg) were administered to 21 cardiac transplant recipients (1 year after transplantation) with normal coronary angiographic results; the serotonin injections were repeated after intracoronary vitamin C supplementation (40 mg/min for 14 minutes). In the segments in which serotonin effects were the most pronounced, the diameter changes were measured by quantitative angiography, and vessel wall morphology was studied by intravascular ultrasound (IVUS). The IVUS examination revealed moderate to severe intimal thickening (total area - luminal area/total area) in 9 patients (group 1) of 25 +/- 2%, compatible with the early stage of graft vasculopathy. In this group, hypersensitivity to serotonin remained unchanged after intracoronary vitamin C supplementation, from -21 +/- 3% (percentage from baseline) to -25 +/- 3%, whereas in the other 12 patients with mild intimal thickening (9 +/- 1%; group 2), hypersensitivity to serotonin was attenuated from -20 +/- 5% to -4 +/- 6% (p <0.01). In contrast, the responses to bradykinin and isosorbide dinitrate were similar in the 2 groups. In group 1, plasma levels of high-sensitivity C-reactive protein and proinflammatory cytokines (interleukin-6 and -8) were significantly enhanced. For all the patients studied, the effect of vitamin C on the response to serotonin was significantly correlated with the intimal thickening. In conclusion, at 1 year after transplantation, morphologic changes compatible with the early stage of the graft vasculopathy are accompanied by hypersensitivity to serotonin unresponsive to vitamin C, despite a relatively preserved endothelial function (unaltered response to bradykinin).
冠状动脉对血清素的超敏反应会促进血小板聚集,进而导致动脉粥样硬化进程的发展。这种异常在心脏移植受者中很常见,可能由活性氧引发,活性氧在炎症过程中起主要作用。因此,本研究旨在确定内膜增生对这种异常的影响以及急性补充超氧阴离子清除剂维生素C后其可逆性。为此,对21名冠状动脉造影结果正常的心脏移植受者(移植后1年)进行冠状动脉内注射血清素(3微克)、缓激肽(600纳克)和硝酸甘油(异山梨醇二硝酸酯200微克);在冠状动脉内补充维生素C(40毫克/分钟,共14分钟)后重复注射血清素。在血清素作用最明显的节段,通过定量血管造影测量直径变化,并通过血管内超声(IVUS)研究血管壁形态。IVUS检查显示,25名患者中有9名(第1组)内膜增厚中度至重度(总面积 - 管腔面积/总面积),为25±2%,符合移植物血管病变的早期阶段。在该组中,冠状动脉内补充维生素C后,对血清素的超敏反应保持不变,从 -21±3%(相对于基线的百分比)变为 -25±3%,而在其他12名内膜轻度增厚的患者(9±1%;第2组)中,对血清素的超敏反应从 -20±5%减弱至 -4±6%(p<0.01)。相比之下,两组对缓激肽和异山梨醇二硝酸酯的反应相似。在第1组中,高敏C反应蛋白和促炎细胞因子(白细胞介素 -6和 -8)的血浆水平显著升高。对于所有研究的患者,维生素C对血清素反应的影响与内膜增厚显著相关。总之,移植后1年,尽管内皮功能相对保留(对缓激肽的反应未改变),但与移植物血管病变早期阶段相符的形态学变化伴有对维生素C无反应的血清素超敏反应。